Holme, Sissel
van Wijk, Richard
Rasmussen, Andreas Ørslev
Petersen, Jesper
Glenthøj, Andreas http://orcid.org/0000-0003-2082-0738
Funding for this research was provided by:
Copenhagen University
Article History
Received: 13 September 2023
Accepted: 16 February 2024
First Online: 28 March 2024
Declarations
:
: The study was approved by the Regional Ethics Committee of the Capital Region of Denmark (H-21064560).
: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: The authors declare the following conflicts of interest: AG: consultant for Agios Pharmaceuticals, Inc., Bristol Myers Squibb, Novartis Pharmaceuticals, Novo Nordisk A/S, Pharmacosmos UK Ltd, and Vertex Pharmaceuticals. Received research support from Agios Pharmaceuticals, Inc., Novo Nordisk A/S, Saniona, and Sanofi. RvW: consultant for Agios Pharmaceuticals. Research funding from Agios Pharmaceuticals and Pfizer. All other authors declare no competing interests.